G. Lorusso, C. R. Barone, N. G. Di Masi, C. Pacifico, L. Maresca, G. Natile
FULL PAPER
using standard Bruker automation programs and pulse sequences.
APT spectra were recorded on a 300-MHz Mercury Varian instru-
ment equipped with z gradient. All spectra were acquired in CDCl3
and at 298 K. ESI mass spectra were obtained through a direct
injection (10 µL/min) of micromolar methanol solutions of all the
compounds into an Agilent 1100 Series LC-MSD Trap System VL
instrument.
3 H), and 2.94 (s, 3 H), CH3N; 2.47 (1 H), 2.62 (1 H), 2.64 (1 H),
and 3.02 (1 H), -CH2N; 2.85 (dd, 1 H), Pt-CH(Ph)CH2NH-
(CH2CH3)2; 2.52 (1 H) and 3.46 (1 H), Pt-CH(Ph)CH2NH-
(CH2CH3)2; 1.36 (3 H) and 1.38 (3 H), Pt-CH(Ph)CH2NH-
(CH2CH3)2; 3.23 (4 H), 3.49 (2 H), and 3.63 (2 H), Pt-CH(Ph)-
CH2NH(CH2CH3)2; 7.13 (1 H, para), 7.21 (2 H, meta), and 7.59
(2 H, ortho), Pt-CH(Ph)CH2NH(CH2CH3)2 ppm. 13C NMR δ =
48.9 and 51.8, CH3N; 59.8 and 66.6, -CH2N; 14.8, Pt-CH(Ph)-
CH2NH(CH2CH3)2; 61.1, Pt-CH(Ph)CH2NH(CH2CH3)2; 7.8 and
9.5, Pt-CH(Ph)CH2NH(CH2CH3)2; 44.2 and 48.3, Pt-CH(Ph)-
CH2NH(CH2CH3)2; 125.9 (para), 128.2 (meta), and 129.0 (ortho),
Pt-CH(Ph)CH2NH(CH2CH3)2 ppm. 195Pt NMR δ = –3294.4 ppm.
M-2bn: 1H NMR δ = 1.69 (dd, 1 H) and 2.25 (dd, 1 H), Pt-
CH2CH(Ph)NH(CH2CH3)2; 4.66 (1 H), Pt-CH2CH(Ph)NH-
(CH2CH3)2 ppm.
Synthesis
Alkene complexes [PtCl(η2-CH2=CHX)(tmeda)](ClO4) (X = CH3,
1a. C6H5, 1b) were prepared by ethene exchange on the cationic
complex [PtCl(η2-C2H4)(tmeda)](ClO4) (1c) by following a re-
ported procedure.[17]
Amine addition compounds 2xy were prepared by reaction of the
alkene complex 1 (0.4 mmol), suspended in dichloromethane
(8 mL), with a slight excess of the amine (NHMe2, m; NHEt2, n;
1.2-fold the stoichiometric amount). After stirring for 3 h at room
temperature, complete dissolution of the solid was observed. The
solution was filtered, the solvent evaporated under reduced pres-
sure, and the oily residue, after trituration with diethyl ether, af-
forded a white solid which was identified as the amine addition
product. The isolated yield, referred to platinum, was ca. 95% for
all the compounds.
Azaplatinacyclobutane complexes 3xy were prepared by treatment
of a dichloromethane solution of the amine addition product 2xy
(0.2 mmol in 0.4 mL solvent) with a water solution of KOH (1.2
times the stoichiometric amount in 0.4 mL solvent). The mixture
was kept under vigorous stirring for 48 h at room temperature. The
organic phase was then removed, washed twice with water (1 mL),
dried with Na2SO4, and submitted to solvent evaporation under
vacuum. The oily residue, triturated with diethyl ether, afforded a
white solid, which was separated by filtration of the solvent and
dried. It was identified as the azaplatinacyclobutane complex. The
isolated yield, referred to platinum, was ca. 90% for all compounds.
2an(ClO4): C13H33Cl2N3O4Pt (561.40): calcd. C 27.81, H 5.92, N
7.48; found C 27.62, H 5.81, N 7.38. NMR (tmeda signals are given
1
first) M-2an: H NMR δ = 2.65 (s, 3 H), 2.67 (s, 3 H), 2.81 (s, 3
H), and 2.87 (s, 3 H), CH3N; 2.56 (1 H) and 2.73 (1 H), 2.82 (1 H)
3an(ClO4): C13H32ClN3O4Pt (524.94): calcd. C 29.74, H 6.14, N
8.00; found C 29.44, H 6.03, N 7.92. NMR (tmeda signals are given
first) M-3an: 1H NMR δ = 2.79 (s, 6 H), 2.80 (s, 6 H), CH3N;
2.35–3.30 (m, 4 H), -CH2N; 1.04 (d, 3 H), Pt{CH2CH(CH3)-
and 3.02 (1 H), -CH2N; 1.26 (d,
NH(CH2CH3)2; 1.46 (dd, 1 H) and 1.59 (dd, 1 H), Pt-CH2CH-
(CH3)NH(CH2CH3)2; 3.59 (m, H), Pt-CH2CH(CH3)NH-
1 H), Pt-CH2CH(CH3)-
1
(CH2CH3)2; 1.43 (m, 3 H) and 1.49 (m, 3 H), Pt-CH2CH(CH3)NH-
(CH2CH3)2; 2.77 (m, 1 H) and 3.34 (m, 1 H), 3.05 (m, 1 H) and
3.28 (m, 1 H), Pt-CH2CH(CH3)NH(CH2CH3)2 ppm. 13C NMR
δ = 47.4, 49.1, 51.1, and 52.2, CH3N; 59.9 and 66.1, -CH2N; 1.0,
2
N(CH2CH3)2-κC,κN}; 0.71 (dd, JPt,H = 87.8 Hz, 1 H) and 1.23
(dd, 1 H), Pt{CH2CH(CH3)N(CH2CH3)2-κC,κN}; 4.35 (m, 1 H),
Pt{CH2CH(CH3)N(CH2CH3)2-κC,κN}; 1.26 (t, 3 H) and 1.64 (t,
3 H), Pt{CH2CH(CH3)N(CH2CH3)2-κC,κN}; 2.58 (m, 1 H) and
2.79 (m, 1 H), 2.92 (m, 1 H) and 3.08 (m, 1 H), Pt{CH2CH(CH3)-
N(CH2CH3)2-κC,κN} ppm. 13C NMR δ = 50.1 and 52.7, CH3N;
–16.08 (1JPt,c = 583.7 Hz), Pt{CH2CH(CH3)N(CH2CH3)2-κC,κN};
21.8, Pt{CH2CH(CH3)N(CH2CH3)2-κC,κN}; 73.5, Pt{CH2CH-
(CH3)N(CH2CH3)2-κC,κN}; 11.7 and 16.2, Pt{CH2CH(CH3)-
N(CH2CH3)2-κC,κN}; 57.4 and 57.6, Pt{CH2CH(CH3)-
N(CH2CH3)2-κC,κN} ppm. 195Pt NMR δ = –3029.6 ppm. anti-M-
Pt-CH2CH(CH3)NH(CH2CH3)2;
15.5,
Pt-CH2CH(CH3)NH-
(CH2CH3)2; 62.6, Pt-CH2CH(CH3)NH(CH2CH3)2; 10.9 and 10.6,
Pt-CH2CH(CH3)NH(CH2CH3)2; 42.8 and 46.8, Pt-CH2CH(CH3)-
NH(CH2CH3)2 ppm. 195Pt NMR δ = –3384.0 ppm. anti-M-2an: 1H
NMR δ = 0.95 (d, 3 H), Pt-CH(CH3)CH2NH(CH2CH3)2; 1.39 (m,
1 H), Pt-CH(CH3)CH2NH(CH2CH3)2; 2.34 (dd, 1 H) and 3.21 (dd,
1 H), Pt-CH(CH3)CH2NH(CH2CH3)2 ppm.
1
3
3an: H NMR δ = 0.63 (d, JPt,H = 64.4 Hz, 3 H), Pt{CH(CH3)-
CH2N(CH2CH3)2-κC,κN}; 1.39 (m, H), Pt{CH(CH3)-
2bm(ClO4): C16H31Cl2N3O4Pt (595.42): calcd. C 32.27, H 5.25, N
1
7.06; found C 32.03, H 5.11, N 6.98. NMR (tmeda signals are given
3
1
CH2N(CH2CH3)2-κC,κN}; 3.79 (dd, 1 H) and 4.71 (dd, JPt,H
78.0 Hz, 1 H), Pt{CH(CH3)CH2N(CH2CH3)2-κC,κN} ppm.
=
first) anti-M-2bm: H NMR δ = 2.46 (s, 3 H), 2.69 (s, 3 H), 2.85
(s, 3 H), and 2.98 (s, 3 H), CH3N; 2.48 (1 H), 2.68 (2 H), and 2.98
2
(1 H), -CH2N; 2.76 (dd, JPt,H = 76.2, 1 H), Pt-CH(Ph)CH2NH-
3bm(ClO4): C16H30ClN3O4Pt (558.96): calcd. C 34.38, H 5.41, N
(CH3)2; 2.32 (1 H) and 3.79 (1 H), Pt-CH(Ph)CH2NH(CH3)2; 3.02
(3 H) and 3.12 (3 H), Pt-CH(Ph)CH2NH(CH3)2; 7.12 (1 H, para),
7.19 (2 H, meta), and 7.40 (2 H, ortho), Pt-CH(Ph)CH2NH(CH3)2
ppm. 13C NMR δ = 48.9, 49.0, and 52.0, CH3N; 59.8 and 66.8,
-CH2N; 16.5 (1JPt,C = 846 Hz), Pt-CH(Ph)CH2NH(CH3)2; 67.6, Pt-
CH(Ph)CH2NH(CH3)2; 42.7 and 45.2, Pt-CH(Ph)CH2NH(CH3)2;
125.3 (para), 128.4 (meta), and 129.2 (ortho), Pt-CH(Ph)-
CH2NH(CH3)2 ppm. M-2bm: 1H NMR δ = 1.77 (dd, 1 H) and 2.08
(dd, 1 H), Pt-CH2CH(Ph)NH(CH3)2; 4.64 (1 H), Pt-CH2CH(Ph)-
NH(CH3)2; 7.40 (3 H, meta and para) and 7.57 (2 H, ortho), Pt-
CH2CH(Ph)NH(CH3)2 ppm. 13C NMR δ = –0.6, Pt-CH2CH(Ph)-
NH(CH3)2; 74.5, Pt-CH2CH(Ph)NH(CH3)2; 129.0 (meta and para)
and 129.6 (ortho), Pt-CH2CH(Ph)NH(CH3)2 ppm.
7.52; found C 34.13, H 5.49, N 7.44. NMR (tmeda signals are given
first) anti-M-3bm: H NMR δ = 1.90 (s, 3 H), 2.69 (s, 3 H), 2.82
1
(s, 3 H), and 2.84 (s, 3 H), CH3N; 2.43 (1 H), 2.56 (1 H), 2.64 (1
2
H), and 2.80 (1 H), -CH2N; 2.85 (dd, JPt,H = 105.4 Hz, 1 H),
Pt{CH(Ph)CH2N(CH3)2-κC,κN}; 4.24 (1 H) and 5.21 (3JPt,H
=
99.4 Hz, 1 H), Pt{CH(Ph)CH2N(CH3)2-κC,κN}; 2.85 (3 H) and
2.89 (3 H), Pt{CH(Ph)CH2N(CH3)2-κC,κN}; 7.14 (1 H, para), 7.20
(2 H, meta), and 7.44 (2 H, ortho), Pt{CH(Ph)CH2N(CH3)2-
κC,κN} ppm. 13C NMR δ = 49.8, 50.5, 51.1, and 53.2, CH3N; 60.5
and 64.8, -CH2N; –6.2 (1JPt,C = 564.4 Hz), Pt{CH(Ph)CH2-
N(CH3)2-κC,κN}; 83.2 (2JPt,C
= 188.2 Hz), Pt{CH(Ph)CH2-
N(CH3)2-κC,κN}; 53.0 and 52.4, Pt{CH(Ph)CH2N(CH3)2-
κC,κN}; 124.6 (para), 128.4 (meta), and 127.8 (ortho), Pt{CH(Ph)-
CH2N(CH3)2-κC,κN} ppm. M-3bm: (not isolated in the solid state
but detected in solution by performing the ring-closing reaction in
2bn(ClO4): C18H35Cl2N3O4Pt (623.47): calcd. C 34.68, H 5.66, N
6.74; found C 34.39, H 5.56, N 6.84. NMR (tmeda signals are given
1
1
first) anti-M-2bn: H NMR δ = 2.42 (s, 3 H), 2.68 (s, 3 H), 2.78 (s,
an NMR tube) H NMR δ = 1.44 (dd, 1 H) and 1.65 (dd, 1 H),
2148
www.eurjic.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2007, 2144–2150